1. Home
  2. Analysis
  3. Meropenem
  4. Erysipelas

Meropenem and Erysipelas - a phase IV clinical study of FDA data

Summary:

Erysipelas is reported as a side effect among people who take Meropenem (meropenem), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Septic shock.

The phase IV clinical study analyzes which people have Erysipelas when taking Meropenem. It is created by eHealthMe based on reports of 33,250 people who have side effects when taking Meropenem from the FDA, and is updated regularly.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

What is Erysipelas?

Erysipelas (bacterial skin infection) is found to be associated with 445 drugs and 645 conditions by eHealthMe. Check the latest studies of Erysipelas.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

33,250 people reported to have side effects when taking Meropenem.
Among them, 14 people (0.04%) have Erysipelas.

Could Meropenem cause Erysipelas?

Among these 14 people:

How long have people been on Meropenem when they have Erysipelas? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Erysipelas when taking Meropenem? *

  • female: 46.15 %
  • male: 53.85 %

What is the age of people who have Erysipelas when taking Meropenem? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Meropenem? *

  1. Pantoprazole: 8 people, 57.14%
  2. Acetaminophen: 5 people, 35.71%
  3. Ibuprofen: 5 people, 35.71%
  4. Atenolol: 4 people, 28.57%
  5. Folic Acid: 4 people, 28.57%
  6. Amlodipine Besylate: 4 people, 28.57%
  7. Perindopril Erbumine: 3 people, 21.43%
  8. Vyxeos: 3 people, 21.43%
  9. Methotrexate Sodium: 3 people, 21.43%
  10. Piperacillin And Tazobactam: 2 people, 14.29%

What are other side effects people have besides Erysipelas? *

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 6 people, 42.86%
  2. Feeding Disorder (when children refuse to eat certain food groups): 4 people, 28.57%
  3. Skin Haemorrhage (bleeding into skin): 4 people, 28.57%
  4. Oral Mucosal Erythema (redness of the mucous membrane of mouth): 4 people, 28.57%
  5. Erythema Multiforme (a type of hypersensitivity reaction): 4 people, 28.57%
  6. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 4 people, 28.57%
  7. Dermo-Hypodermitis (skin and subcutaneous tissue bacterial infections): 4 people, 28.57%
  8. Rash Pruritic (redness with itching): 4 people, 28.57%
  9. Septic Shock (shock due to blood infection): 4 people, 28.57%
  10. Stenotrophomonas Infection: 4 people, 28.57%

What are the existing conditions these people have? *

  1. Septic Shock (shock due to blood infection): 5 people, 35.71%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 28.57%
  3. Infection: 4 people, 28.57%
  4. Cardiac Failure: 3 people, 21.43%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 21.43%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 14.29%
  7. Cardiac Failure Chronic: 2 people, 14.29%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 14.29%
  9. Cough: 1 person, 7.14%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and have Erysipelas?

- Check whether Erysipelas is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Meropenem:

Erysipelas treatments and more:

How severe was Erysipelas and when was it recovered:

Expand to all the drugs that have ingredients of meropenem:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Erysipelas:

Browse all the conditions that are associated with Erysipelas:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on meropenem (the active ingredients of Meropenem) and Meropenem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.